Form 4: Acacia Research Director Michelle Felman Receives Annual Equity Grant
Insider Transaction Report
Acacia Research Corporation's Director, Michelle Felman, was granted 32,172 shares of common stock as part of the company's annual non-employee director equity awards, vesting fully on the first anniversary of the grant date.
Summary
- Michelle Felman, a Director of Acacia Research Corp (ACTG), received a grant of 32,172 shares of ACTG Common Stock on May 30, 2025.
- This grant was part of the Company's annual equity awards for non-employee directors.
- The shares were awarded pursuant to the 2024 Acacia Research Corporation Stock Incentive Plan.
- The restricted stock will vest 100% on the first anniversary of the grant date.
- Following this transaction, Michelle Felman beneficially owns 55,293 shares of ACTG Common Stock.
Sentiment
Score: 6
Explanation: The filing reports a routine and expected equity grant to a director, which is a positive for aligning interests but does not indicate significant new financial performance or strategic shifts.
Positives
- The grant of restricted stock to a non-employee director aligns the director's interests with those of the shareholders, promoting long-term value creation.
- The transaction is part of a pre-existing, approved equity incentive plan (2024 Acacia Research Corporation Stock Incentive Plan), indicating a structured approach to director compensation.
Negatives
- No specific negative aspects are discernible from this routine insider transaction filing.
Risks
- No specific risks are mentioned in this Form 4 filing, as it primarily reports an insider transaction.
Future Outlook
The restricted stock granted to Michelle Felman is scheduled to vest 100% on the first anniversary of the grant date, May 30, 2025.
Industry Context
This Form 4 filing reports a routine insider transaction, specifically an equity grant to a non-employee director. Such grants are a common practice across industries to compensate directors and align their interests with shareholders, reflecting standard corporate governance practices rather than specific industry trends.
Management Changes
| Role | Previous Person | New Person | Effective Date | Reason |
|---|---|---|---|---|
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Equity Compensation | Grant of restricted stock to a non-employee director under the 2024 Acacia Research Corporation Stock Incentive Plan. | 05/30/2025 | Aligns director's long-term interests with shareholder value through equity ownership and performance incentives. |
Legal Proceedings
- No legal proceedings are mentioned in this document.
Related Party Transactions
- This document reports an equity grant to a director, which is an insider transaction. While it involves a 'related party' (the director), it is a standard compensation practice rather than a specific related party transaction requiring separate disclosure of non-arm's length terms.
Stakeholder Impact
- Shareholders: The grant aligns the director's financial interests with those of the shareholders, potentially encouraging decisions that enhance long-term shareholder value.
- Employees: No direct impact on employees is mentioned.
- Customers: No direct impact on customers is mentioned.
- Suppliers: No direct impact on suppliers is mentioned.
- Creditors: No direct impact on creditors is mentioned.
Next Steps
- Vesting of the 32,172 restricted shares on May 30, 2026.
Key Dates
| Date | Description |
|---|---|
| 05/30/2025 | Date of grant of restricted stock to Michelle Felman. |
| 06/03/2025 | Date the Form 4 was signed by the attorney-in-fact. |
| 05/30/2026 | Expected vesting date for 100% of the restricted stock grant (first anniversary of grant date). |
Keywords
Acacia Research, ACTG, Michelle Felman, Director, Equity Grant, Restricted Stock, SEC Form 4, Insider Transaction, Stock Incentive Plan, Corporate Governance
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.